LWIC
ABBV icon

Leith Wheeler Investment Counsel’s AbbVie ABBV Stock Holding History

Leith Wheeler Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,252
Closed -$2.05M – 59
2023
Q2 		$2.05M Buy
15,252
+1,250
+9% +$183K 0.27% 51
2023
Q1 		$2.23M Buy
14,002
+900
+7% +$138K 0.33% 47
2022
Q4 		$2.12M Buy
13,102
+3,150
+32% +$483K 0.32% 48
2022
Q3 		$1.34M Buy
9,952
+3,350
+51% +$481K 0.22% 47
2022
Q2 		$1.3M Buy
6,602
+2,733
+71% +$418K 0.17% 49
2022
Q1 		$627K Buy
+3,869
New +$562K 0.09% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Leith Wheeler Investment Counsel's ABBV Position: Q3 2023 in Review

Leith Wheeler Investment Counsel sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 15,252 shares — an estimated $2.05M sold.

Leith Wheeler Investment Counsel first reported a position in ABBV in Q1 2022 and held it in 6 quarters. The position peaked at $2.23M in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Leith Wheeler Investment Counsel reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Leith Wheeler Investment Counsel sold 15,252 AbbVie shares in Q3 2023, an estimated $2.05M.
  • Leith Wheeler Investment Counsel first reported a position in AbbVie in Q1 2022 and held it in 6 quarters.
  • Leith Wheeler Investment Counsel's AbbVie position peaked at $2.23M in Q1 2023.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Leith Wheeler Investment Counsel's 13F filing for Q3 2023, filed 27 Oct 2023.